Gene Ontology Assessment of Indirect Cold Physical Plasma and UV-Radiation Molecular Mechanism at the Cellular Level Gene ontology assessment of indirect cold physical plasma and UV-radiation
Journal of Lasers in Medical Sciences,
Vol. 14 (2023),
29 January 2023
,
Page e10
Abstract
Introduction: The development of therapeutic methods implies an understanding of the molecular mechanism of the applied methods. Due to the widespread use of UV radiation and cold physical plasma in medicine, the molecular mechanism of these two methods is compared via gene ontology.
Methods: Data were derived from Gene Expression Omnibus (GEO). The differentially expressed genes (DEGs) which discriminate the cells treated with UV radiation versus indirect cold physical plasma were analyzed via gen ontology enrichment. The related biochemical pathways were extracted from the “Kyoto Encyclopedia of Genes and Genomes” (KEGG).
Results: Among the 152 queried DEGs, 18 critical genes including SOC1, LDLR, ALO5, PTGS2, TNF, JUNB, TNFRSF1A, CD40, SMAD7, ID1, SMAD6, SERPINE1, PMAIP1, MDM2, CREB5, GADD45A, E2F3, and ETV5 were highlighted as the genes that victimize the two methods.
Conclusion: NOTCH1 and TNF as the main genes plus SEREPINE1, KLF, and BDNF were introduced as the significant genes that are involved in the processes which discriminate cold physical plasma administration and UV-radiation as the two evaluated therapeutic methods.
- Chemical pathway analysis, cold physical plasma, UV-radiation, gene expression change, gene ontology
How to Cite
References
2. Smith GL, Ganz PA, Bekelman JE, Chmura SJ, Dignam JJ, Efstathiou JA, et al. Promoting the appropriate use of advanced radiation technologies in oncology: summary of a national cancer policy forum workshop. International Journal of Radiation Oncology* Biology* Physics. 2017;97(3):450-61.
3. Dubey SK, Dabholkar N, Pal UN, Singhvi G, Sharma NK, Puri A, et al. Emerging innovations in cold plasma therapy against cancer: a paradigm shift. Drug Discovery Today. 2022.
4. Wang C, Cheng L, Liu Z. Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics. 2013;3(5):317.
5. Allegra A, Pioggia G, Tonacci A, Musolino C, Gangemi S. Oxidative stress and photodynamic therapy of skin cancers: Mechanisms, challenges and promising developments. Antioxidants. 2020;9(5):448.
6. Laikova KV, Oberemok VV, Krasnodubets AM, Gal’chinsky NV, Useinov RZ, Novikov IA, et al. Advances in the understanding of skin cancer: ultraviolet radiation, mutations, and antisense oligonucleotides as anticancer drugs. Molecules. 2019;24(8):1516.
7. Tabares FL, Junkar I. Cold plasma systems and their application in surface treatments for medicine. Molecules. 2021;26(7):1903.
8. Harley JC, Suchowerska N, McKenzie DR. Cancer treatment with gas plasma and with gas plasma–activated liquid: Positives, potentials and problems of clinical translation. Biophysical Reviews. 2020;12(4):989-1006.
9. Guéguen Y, Bontemps A, Ebrahimian TG. Adaptive responses to low doses of radiation or chemicals: their cellular and molecular mechanisms. Cellular and Molecular Life Sciences. 2019;76(7):1255-73.
10. Marques DA, Jones FC, Di Palma F, Kingsley DM, Reimchen TE. Experimental evidence for rapid genomic adaptation to a new niche in an adaptive radiation. Nature ecology & evolution. 2018;2(7):1128-38.
11. Onik JC, Xie Y, Duan Y, Hu X, Wang Z, Lin Q. UV-C treatment promotes quality of early ripening apple fruit by regulating malate metabolizing genes during postharvest storage. PloS one. 2019;14(4):e0215472.
12. Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Research. 2022.
13. Li W. Volcano plots in analyzing differential expressions with mRNA microarrays. Journal of bioinformatics and computational biology. 2012;10(06):1231003.
14. Williamson DF, Parker RA, Kendrick JS. The box plot: a simple visual method to interpret data. Annals of internal medicine. 1989;110(11):916-21.
15. Singh AJ, Ramsey SA, Filtz TM, Kioussi C. Differential gene regulatory networks in development and disease. Cellular and Molecular Life Sciences. 2018;75(6):1013-25.
16. Tavirani MR, Azodi MZ, Rostami-Nejad M, Morravej H, Razzaghi Z, Okhovatian F, et al. Introducing Serine as cardiovascular disease biomarker candidate via pathway analysis. Galen Medical Journal. 2020;9:e1696.
17. Gharaibeh L, Elmadany N, Alwosaibai K, Alshaer W. Notch1 in cancer therapy: possible clinical implications and challenges. Molecular pharmacology. 2020;98(5):559-76.
18. Chu W-M. Tumor necrosis factor. Cancer letters. 2013;328(2):222-5.
19. Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches. Cellular Oncology. 2020;43(1):1-18.
- Abstract Viewed: 630 times
- PDF Downloaded: 537 times